Assessment of the ADLIFE intervention as a digital solution for patients with advanced chronic diseases: a quasi-experimental trial

Borja García-Lorenzo, Ania Gorostiza, Nerea González, Igor Larrañaga, Ángel Moro, Ana Ortega-Gil, Beñat Zubelzu, Remedios Vega, Laura de La Higuera, Rachelle Kaye, Gil Levy, Olga Vishnevetsky, Anne Dichmann Sorknæs, Rikke Lyngholm Christensen, Natassia Kamilla Juul, Harpal Randeva, Tim Robbins, Michelle Yorkston, Gokce B. Laleci Erturkmen, Mustafa Yuksel, Bunyamin Sarigul, Theodoros N. Arvanitis, Omid Pournik, Chao Tong, José I. Aznar-Baranda, Jessica Caballero-García, Gontzal Vallejo-Setién, Mikael Lilja, Marie Holm Sherman, Anne Swoboda, Oliver Groene, Janika Bloemeke-Cammin, Dipak Kalra, Roma Maguire, Lisa McCann, Morven Miller, Nicolás Francisco González López, Leire Ortiz de Elguea, Miguel Ángel Ogueta Lana, Itxaso Alayo, Urko Aguirre, Barbara López Perea, Michal Yeshayahu, Elinor Dahary Halevy, Shramika Panchal, Gokhan Yılmaz, Juan de La Torre, Dolores Verdoy, Esteban de Manuel Keenoy, Ane Fullaondo

Open source

DOI
10.1038/s41746-026-02716-0
Published
2026-05-21
Container
npj Digital Medicine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41746-026-02716-0,
  title = {Assessment of the ADLIFE intervention as a digital solution for patients with advanced chronic diseases: a quasi-experimental trial},
  author = {Borja García-Lorenzo and Ania Gorostiza and Nerea González and Igor Larrañaga and Ángel Moro and Ana Ortega-Gil and Beñat Zubelzu and Remedios Vega and Laura de La Higuera and Rachelle Kaye and Gil Levy and Olga Vishnevetsky and Anne Dichmann Sorknæs and Rikke Lyngholm Christensen and Natassia Kamilla Juul and Harpal Randeva and Tim Robbins and Michelle Yorkston and Gokce B. Laleci Erturkmen and Mustafa Yuksel and Bunyamin Sarigul and Theodoros N. Arvanitis and Omid Pournik and Chao Tong and José I. Aznar-Baranda and Jessica Caballero-García and Gontzal Vallejo-Setién and Mikael Lilja and Marie Holm Sherman and Anne Swoboda and Oliver Groene and Janika Bloemeke-Cammin and Dipak Kalra and Roma Maguire and Lisa McCann and Morven Miller and Nicolás Francisco González López and Leire Ortiz de Elguea and Miguel Ángel Ogueta Lana and Itxaso Alayo and Urko Aguirre and Barbara López Perea and Michal Yeshayahu and Elinor Dahary Halevy and Shramika Panchal and Gokhan Yılmaz and Juan de La Torre and Dolores Verdoy and Esteban de Manuel Keenoy and Ane Fullaondo},
  year = {2026},
  journal = {npj Digital Medicine},
  doi = {10.1038/s41746-026-02716-0},
  url = {https://doi.org/10.1038/s41746-026-02716-0}
}

RIS

TY  - JOUR
TI  - Assessment of the ADLIFE intervention as a digital solution for patients with advanced chronic diseases: a quasi-experimental trial
AU  - Borja García-Lorenzo
AU  - Ania Gorostiza
AU  - Nerea González
AU  - Igor Larrañaga
AU  - Ángel Moro
AU  - Ana Ortega-Gil
AU  - Beñat Zubelzu
AU  - Remedios Vega
AU  - Laura de La Higuera
AU  - Rachelle Kaye
AU  - Gil Levy
AU  - Olga Vishnevetsky
AU  - Anne Dichmann Sorknæs
AU  - Rikke Lyngholm Christensen
AU  - Natassia Kamilla Juul
AU  - Harpal Randeva
AU  - Tim Robbins
AU  - Michelle Yorkston
AU  - Gokce B. Laleci Erturkmen
AU  - Mustafa Yuksel
AU  - Bunyamin Sarigul
AU  - Theodoros N. Arvanitis
AU  - Omid Pournik
AU  - Chao Tong
AU  - José I. Aznar-Baranda
AU  - Jessica Caballero-García
AU  - Gontzal Vallejo-Setién
AU  - Mikael Lilja
AU  - Marie Holm Sherman
AU  - Anne Swoboda
AU  - Oliver Groene
AU  - Janika Bloemeke-Cammin
AU  - Dipak Kalra
AU  - Roma Maguire
AU  - Lisa McCann
AU  - Morven Miller
AU  - Nicolás Francisco González López
AU  - Leire Ortiz de Elguea
AU  - Miguel Ángel Ogueta Lana
AU  - Itxaso Alayo
AU  - Urko Aguirre
AU  - Barbara López Perea
AU  - Michal Yeshayahu
AU  - Elinor Dahary Halevy
AU  - Shramika Panchal
AU  - Gokhan Yılmaz
AU  - Juan de La Torre
AU  - Dolores Verdoy
AU  - Esteban de Manuel Keenoy
AU  - Ane Fullaondo
PY  - 2026
JO  - npj Digital Medicine
DO  - 10.1038/s41746-026-02716-0
UR  - https://doi.org/10.1038/s41746-026-02716-0
ER  - 

APA

García-Lorenzo, B., Gorostiza, A., González, N., Larrañaga, I., Moro, Á., Ortega-Gil, A., Zubelzu, B., Vega, R., Higuera, L. D. L., Kaye, R., Levy, G., Vishnevetsky, O., Sorknæs, A. D., Christensen, R. L., Juul, N. K., Randeva, H., Robbins, T., Yorkston, M., Erturkmen, G. B. L., Yuksel, M., Sarigul, B., Arvanitis, T. N., Pournik, O., Tong, C., Aznar-Baranda, J. I., Caballero-García, J., Vallejo-Setién, G., Lilja, M., Sherman, M. H., Swoboda, A., Groene, O., Bloemeke-Cammin, J., Kalra, D., Maguire, R., McCann, L., Miller, M., López, N. F. G., Elguea, L. O. D., Lana, M. Á. O., Alayo, I., Aguirre, U., Perea, B. L., Yeshayahu, M., Halevy, E. D., Panchal, S., Yılmaz, G., Torre, J. D. L., Verdoy, D., Keenoy, E. D. M., & Fullaondo, A. (2026). Assessment of the ADLIFE intervention as a digital solution for patients with advanced chronic diseases: a quasi-experimental trial. npj Digital Medicine. https://doi.org/10.1038/s41746-026-02716-0

Source records